Publications:25
Accepting New Patients
Mount Sinai DoctorsTreats Adults
Accepting New PatientsSuchitra Sundaram, MD
Hematology-Oncology, Cancer (Oncology)
No Patient Experience Ratings
Book an Appointment
About Me
Dr. Suchitra Sundaram is an Assistant Professor of Medicine (Hematology and Medical Oncology) at the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai. Dr. Sundaram provides clinical care fully dedicated to patients with lymphoma (non-hodgkin and hodgkin lymphoma) and chronic lymphocytic leukemia (CLL). Her research focuses on the development of novel targeted therapies in lymphoma and CLL and studying practice patterns and clinical outcomes of lymphoma in the real world setting. Dr. Sundaram is a primary investigator and and a co-investigator on several multi-center clinical trials that tested combinations of novel agents and immunotherapies to precisely target lymphoma while decreasing the intensity of side effects. Dr. Sundaram was also involved in translational and laboratory based research projects and contributed to studying the biology of treatment resistance in lymphoma/CLL, evaluating novel small-molecule inhibitors targeting key-regulatory pathways in lymphomas and identification of biomarkers of response. She has authored and co-authored several articles in scientific journals, as well as had several national level meeting abstracts and presentations. Dr. Sundaram has served on the NCCN CLL- Hairy Cell Leukemia practice guidelines committee and has been involved in speaker events with the Leukemia Lymphoma Society and the Lymphoma Research Foundation. Dr. Sundaram is a Lymphoma Research Foundation Scholar and is committed to continuing her research in lymphoma outcomes studies and clinical trials with the hope to provide the most appropriate individualized care plan for her patients.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
About Me
Dr. Suchitra Sundaram is an Assistant Professor of Medicine (Hematology and Medical Oncology) at the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai. Dr. Sundaram provides clinical care fully dedicated to patients with lymphoma (non-hodgkin and hodgkin lymphoma) and chronic lymphocytic leukemia (CLL). Her research focuses on the development of novel targeted therapies in lymphoma and CLL and studying practice patterns and clinical outcomes of lymphoma in the real world setting. Dr. Sundaram is a primary investigator and and a co-investigator on several multi-center clinical trials that tested combinations of novel agents and immunotherapies to precisely target lymphoma while decreasing the intensity of side effects. Dr. Sundaram was also involved in translational and laboratory based research projects and contributed to studying the biology of treatment resistance in lymphoma/CLL, evaluating novel small-molecule inhibitors targeting key-regulatory pathways in lymphomas and identification of biomarkers of response. She has authored and co-authored several articles in scientific journals, as well as had several national level meeting abstracts and presentations. Dr. Sundaram has served on the NCCN CLL- Hairy Cell Leukemia practice guidelines committee and has been involved in speaker events with the Leukemia Lymphoma Society and the Lymphoma Research Foundation. Dr. Sundaram is a Lymphoma Research Foundation Scholar and is committed to continuing her research in lymphoma outcomes studies and clinical trials with the hope to provide the most appropriate individualized care plan for her patients.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Clinical Focus
- Adult Non-Hodgkin's Lymphoma
- Bone Marrow Biopsy
- Cancer Treatment
- Enlarged Lymph Nodes
- Hairy Cell Leukemia
- Hematologic Malignancies
- Hematology
- Hodgkin's Disease
- Hodgkin's Lymphoma
Show More
Education
MBBS, Lokmanya Tilak Municipal Medical College
Residency, Internal Medicine
Cleveland Clinic Foundation
Fellowship, Hematology & Oncology
University Hospitals Cleveland Medical Center
Certifications
American Board of Internal Medicine
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
- Ruttenberg Treatment Center1470 Madison Avenue, 3rd Floor, New York, NY, 10029
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series. Narendranath Epperla, Adam S. Zayac, Daniel J. Landsburg, Allison M. Bock, Grzegorz S. Nowakowski, Emily C. Ayers, Mark Girton, Marie Hu, Amy Beckman, Shaoying Li, L. Jeffrey Medeiros, Julie E. Chang, Habibe Kurt, Jose Sandoval-Sus, Mohammad Ali Ansari-Lari, Shalin K. Kothari, Anna Kress, Mina L. Xu, Pallawi Torka, Suchitra Sundaram, Stephen D. Smith, Kikkeri N. Naresh, Yasmin Karimi, David A. Bond, Andrew M. Evens, Seema G. Naik, Manali Kamdar, Bradley M. Haverkos, Reem Karmali, Umar Farooq, Julie M. Vose, Paul Rubinstein, Amina Chaudhry, Adam J. Olszewski. Blood advances
- Targeted BET inhibition with OPN-51107 synergizes with venetoclax in chronic lymphocytic leukemia. Kevin G. Zablonski, Sydney A. Skupa, Alexandria P. Eiken, Suchitra Sundaram, Cory Mavis, Juan Gu, Pallawi Torka, Paola Ghione, Dalia El-Gamal, Francisco J. Hernandez-Ilizaliturri. Leukemia and Lymphoma
- Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outcomes. Charlotte B. Wagner, Ken Boucher, Adrienne Nedved, Ivana N. Micallef, Sanjal Desai, Haris Hatic, Gaurav Goyal, Erin Zacholski, Amanda Fegley, Audrey M. Sigmund, David A. Bond, Courtney Samuels, Manali K. Kamdar, Sheeba Ba Aqeel, Pallawi Torka, Kira MacDougall, Azra Borogovac, Sridevi Rajeeve, Suchitra Sundaram, Kalub Fedak, Dipenkumar Modi, Elizabeth Travers, Sabarish Ayyappan, Nitin Chilakamarri, Elizabeth A. Brem, Daniel A. Ermann, Lindsey A. Fitzgerald, Boyu Hu, Deborah M. Stephens, Harsh Shah. Haematologica
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Sundaram has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Sundaram has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.